PutinXi Talks Could Revive Stalled Power of Siberia 2 Gas Pipeline Amid Iran Conflict Yaashvi Jewellers IPO Attracts 118x Subscription on Final Day of Bidding US Funds Build Cash Reserves Ahead of Anticipated SpaceX and OpenAI Public Listings SP 500 Barely Budges as Consumer Spending Strength Offsets Energy Slump Paul Tudor Jones Says No Chance Kevin Warsh Will Cut Fed Rates Marvell Technology Eyes Key Catalyst Ahead of May 27 Event Analyst Sentiment and Market Positioning VSCO Q1 2026 Earnings Earnings Beat Estimates Despite Limited Revenue Disclosure HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress BL Q1 2026 Earnings EPS Surpasses Expectations by Over 21 BHFAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter ZenaTech Inc ZENA Q4 2025 Earnings Deep Loss Misses Estimates Despite Share Rally Kimball Electronics Inc KE Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower Euronet Worldwide EEFT Gains 128 as Stock Approaches Key Resistance at 7367 SMJ International Holdings SMJF Edges Higher in Quiet Session Tests Middle of Range New Pacific Metals NEWP Surges 42 as Shares Approach Key Resistance Level CBRE Group Inc CBRE Posts Slight Decline Amid Sector Headwinds Key Levels in Focus Diamondback Energy FANG Holds Steady Near Key Resistance as Energy Sector Shows Mixed Signals ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance LYEL Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency and Pipeline Progress Kestra Medical Technologies KMTS Q1 2026 Earnings EPS Misses Estimates as Company Advances Pipeline Shares Edge Higher ENPH Q1 2026 Earnings EPS Surprises to the Upside as Stock Gains 27 IFF Q1 2026 Earnings EPS Surges Past Estimates on Operational Efficiency Ridgepost Capital Inc RPC Q1 2026 Earnings Slight EPS Beat Amid Mixed Signals Stock Slips Global Worker Confidence Plunges to Record Low Amid AI Job Displacement Fears DTIL Q1 2026 Earnings EPS Misses Estimates as Gene Editing Pipeline Progress Takes Center Stage Kura Oncology KURA Stages a Rally Testing Key Resistance at 12